SPOTLIGHT: Stem cell therapy for bones nearing human trials


An Edinburgh University team of researchers has been using a bioactive scaffold to help spur stem cells to grow into bone or cartilage. The researchers say the approach can be tested in humans in two years for severe trauma. Report

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.